Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Al-Sarraf

Showing results (31-40 of 145) with videos related to

Pageof 15
Sort By:
Hematology/Oncology Clinics of North America|August 1, 1991
The Wayne State University experience with adjuvant chemotherapy of head and neck cancerM al-Sarraf, J A Kish, J F Ensley
Surgery, Gynecology & Obstetrics|November 1, 1979
Clinical presentation, natural history and prognostic factors in advanced malignant melanomaM H Amer, M Al-Sarraf, V K Vaitkevicius
American Journal of Clinical Oncology|August 1, 1988
Response rate and toxicity with aziridinylbenzoquinone in patients with recurrent gliomas. A progress reportE Tapazoglou, J Kish, J Ensley, et al.
American Journal of Clinical Oncology|February 1, 1990
Phase II evaluation of 4'deoxydoxorubicin in advanced renal cell carcinomaJ A Kish, J F Ensley, M al-Sarraf
Cancer Treatment Reports|June 1, 1979
Combination of adriamycin and cyclophosphamide in the treatment of metastatic prostatic carcinoma: a phase II studyR M Izbicki, M H Amer, M Al-Sarraf
Cancer|June 1, 1979
Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancerM H Amer, M Al-Sarraf, V K Vaitkevicius
Cancer Treatment Reports|April 1, 1979
Phase II trial of dianhydrogalactitol in metastatic malignant melanoma: a Southwest Oncology Group studyJ T Thigpen, M Al-Sarraf, J S Hewlett
Experientia|May 15, 1974
Feto-specific features of human beta2-microglobulinJ Cejka, K Kithier, J Belamaric, et al.
Cancer|March 15, 1986
The activity of a single-agent 5-fluorouracil infusion in advanced and recurrent head and neck cancerE Tapazoglou, J Kish, J Ensley, et al.
Archives of Pathology|June 1, 1971
Malignant granular cell tumor. Histochemical and electron microscopic studyM al-Sarraf, A V Loud, V K Vaitkevicius
Pageof 15

Showing results (31-40 of 145) with videos related to

Sort By:
Pageof 15
Hematology/Oncology Clinics of North America|August 1, 1991
The Wayne State University experience with adjuvant chemotherapy of head and neck cancerM al-Sarraf, J A Kish, J F Ensley
Surgery, Gynecology & Obstetrics|November 1, 1979
Clinical presentation, natural history and prognostic factors in advanced malignant melanomaM H Amer, M Al-Sarraf, V K Vaitkevicius
American Journal of Clinical Oncology|August 1, 1988
Response rate and toxicity with aziridinylbenzoquinone in patients with recurrent gliomas. A progress reportE Tapazoglou, J Kish, J Ensley, et al.
American Journal of Clinical Oncology|February 1, 1990
Phase II evaluation of 4'deoxydoxorubicin in advanced renal cell carcinomaJ A Kish, J F Ensley, M al-Sarraf
Cancer Treatment Reports|June 1, 1979
Combination of adriamycin and cyclophosphamide in the treatment of metastatic prostatic carcinoma: a phase II studyR M Izbicki, M H Amer, M Al-Sarraf
Cancer|June 1, 1979
Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancerM H Amer, M Al-Sarraf, V K Vaitkevicius
Cancer Treatment Reports|April 1, 1979
Phase II trial of dianhydrogalactitol in metastatic malignant melanoma: a Southwest Oncology Group studyJ T Thigpen, M Al-Sarraf, J S Hewlett
Experientia|May 15, 1974
Feto-specific features of human beta2-microglobulinJ Cejka, K Kithier, J Belamaric, et al.
Cancer|March 15, 1986
The activity of a single-agent 5-fluorouracil infusion in advanced and recurrent head and neck cancerE Tapazoglou, J Kish, J Ensley, et al.
Archives of Pathology|June 1, 1971
Malignant granular cell tumor. Histochemical and electron microscopic studyM al-Sarraf, A V Loud, V K Vaitkevicius
Pageof 15